Litigation Details for RECKITT BENCKISER LLC v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2015)
✉ Email this page to a colleague
RECKITT BENCKISER LLC v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-03-26 |
Court | District Court, D. New Jersey | Date Terminated | 2017-08-22 |
Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
Jury Demand | None | Referred To | Joel Schneider |
Patents | 6,372,252; 6,955,821; 7,838,032 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in RECKITT BENCKISER LLC v. AMNEAL PHARMACEUTICALS LLC
Details for RECKITT BENCKISER LLC v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-10-25 | 244 | infringe U.S. Patent Nos. 6,372,252 (the “'252 Patent”), 6,955,821 (the “'821 Patent”), and 7,838,032…#39;252 Patent as to all Defendants [Docket Nos. 64, 65] and its claims under the '821 Patent against…product and the '252 patent, which Reckitt had withdrawn (and other patents). As stated by the Aurobindo…Reckitt Benckiser LLC (“Plaintiff”) brought this patent infringement case against Defendants Amneal Pharmaceuticals…Defendants’ products did not infringe the two patents at issue. Reckitt Benckiser LLC v, Amneal Pharm | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |